The U.S. Food and Drug Administration (FDA) has approved the expansion of the indication of mometasone furoate monohydrate (Nasonex) for the treatment of seasonal and perennial nasal allergy ...

Nasal Spray: two sprays (50 mcg of mometasone furoate in each spray) in each nostril once daily (total daily dose of 200 mcg).

Mometasone Furoate Monohydrate Nasal Spray is used for treating nasal symptoms of seasonal allergic and perennial allergic rhinitis, in adults and paediatric patients aged two years and older.

Mometasone (as furoate monohydrate) 50mcg/spray. Mometasone is a corticosteroid demonstrating potent anti-inflammatory properties. The precise mechanism of corticosteroid action on allergic ...

Perrigo announced that the FDA has approved mometasone furoate monohydrate, an intranasal corticosteroid nasal spray designed to treat and prevent hay fever and allergy symptoms, for over-the ...

Apotex announced the launch of Mometasone Furoate Monohydrate Nasal Spray, the generic version of Merck's Nasonex.

Aurobindo Pharma will manufacture and market Mometasone Furoate Monohydrate Nasal Spray (50 mcg/spray), which is bioequivalent and therapeutically equivalent to the reference listed drug (RLD) Nasonex ...

Mometasone furoate monohydrate, 50 μg nasal spray (Nasonex, Schering-Plough), is approved by the FDA for the treatment of allergic rhinitis and nasal congestion associated with seasonal allergic ...

Each inhalation contains 5 mcg of formoterol fumarate and either 100 mcg or 200 mcg of mometasone furoate. The recommended starting dose is based on prior asthma therapy.

ASMANEX, indicated for the maintenance treatment of asthma as prophylactic therapy in patients four years of age and older, is now available in pharmacies nationwide.

Mosaspray™ is the first non-prescription formulation in Canada of mometasone furoate, a corticosteroid used to relieve the symptoms of allergic rhinitis, otherwise known as hay fever.

Nasonex is therapeutic equivalent of mometasone furoate and is offered in 50 mcg/spray strength. Increasing research and development activities related to mometasone furoate are expected to drive ...